Abstract. In the last three decades, several models on the interaction of glucose and insulin following the intra venous glucose tolerance test (IVGTT) have appeared in the literature. One of the mostly used one is generally known as the "minimal model" which was first published in 1979 and modified in 1986. Recently, this minimal model has been challenged by De Gaetano and Arino [4] from both physiological and modeling aspects. Instead, they proposed a new and mathematically more reasonable model, called "dynamic model". Their model makes use of certain simple and specific functions and introduces time delay in a particular way. The outcome is that the model always admits a globally asymptotically stable steady state. The objective of this paper is to find out if and how this outcome depends on the specific choice of functions and the way delay is incorporated. To this end, we generalize the dynamical model to allow more general functions and an alternative way of incorporating time delay. Our findings show that in theory, such models can possess unstable positive steady states. However, for all conceivable realistic data, such unstable steady states do not exist. Hence, our work indicates that the dynamic model does provide qualitatively robust dynamics for the purpose of clinic application. We also perform simulations based on data from a clinic study and point out some plausible but important implications.
1. Introduction. The dynamic relationship between glucose and its controlling hormone insulin has been mathematically modeled and studied by many researchers since the sixties ( [2] , [10] , [12] , [14] , [17] , [20] , [7] , and the references cited in [6] ). Most of these models consist of several ordinary differential equations, the number of equations is often proportional to that of factors considered. Some of these equations are simply linear and were judged unacceptable for various reasons [1] , such as parameters are not identifiable or have poor fits to experimental data.
Due to the increased occurrence of pathological conditions such as diabetes, obesity, and cardiovascular diseases, the quantification of insulin sensitivity from some relatively non-invasive tests has gained increased interest and importance in physiological research. This lead to some new studies on the existing models and the introduction of some alternative ones. Currently, the most widely used model in physiological research on the metabolism of glucose is the so-called "minimal model", which describes intra venous glucose tolerance test (IVGTT) experimental data well with the smallest set of identifiable and meaningful parameters ( [1] , [13] ). After incorporating the insulin dynamics, it takes the form of [4] (1.1)
The initial conditions are:
Here G(t) [ ] is the rate of pancreatic release of insulin after the intake of the glucose bolus, per minute per unit of glucose concentration above the "target" glycemia b 5 [mg/dl]. b 6 [µUI/ml] is the first order decay rate for insulin in plasma. b 7 [µUI/ml] is the plasma insulin concentration at time 0, above basal insulinemia, immediately after the glucose bolus intake.
While the above minimal model has minimal number of constant(b 0 − b 7 ), and has been very useful in physiological research works, [4] argues that it has the following three drawbacks associated with it. For this model, the parameter fitting is to be divided into two separate parts: first, using the recorded insulin concentration as given input data in order to derive the parameters in the first two equations in the model, then using the recorded glucose concentration as given input to derive the parameters in the third equation. However, the system is an integrated physiological dynamic system and one should treat it as a whole and be able to conduct a single-step parameter fitting process. Secondly, some of the mathematical results produced by this model are not realistic. Specifically, it can be shown that the minimal model dose not admit an equilibrium and the solutions may not be bounded. Finally, the non-observable auxiliary variable X(t) is artificially introduced to delay the action of insulin on glucose. An alternative and natural way is to explicitly introduce the time delay in the model. To address these issues, De Gaetano and Arino [4] introduced the following aggregated delay differential model which they named it as "dynamic model." It takes the form of
(1.
2)
The initial condition now takes the form of
As in the minimal model, While the dynamic model solves the problems of minimal model, it implicitly or explicitly made a few assumptions that may not be necessary or realistic. Specifically some of the interaction terms are too special and thus too restrictive. For example, the term b 4 I(t)G(t) assumes mass action law applies here. A more popular, general and realistic alternative is to replace this term by b 4 
I(t)G(t)/(αG(t)+1).
Since in a unit of time, a unit of insulin can only process a limited amount of glucose. Also the way the delay is introduced is somewhat restrictive, the justification of which consists of only one subjective assumption "the delay term refers to the pancreatic secretion of insulin: effective pancreatic secretion at time t is considered to be proportional to the average value of glucose concentration in the b 5 minutes preceding time t". This naturally invites other plausible ways of incorporating the time delay. The most noteworthy outcome of the dynamical model is that it always admits a globally asymptotically stable steady state. The objective of this paper is to find out if and how this outcome depends on the specific choice of functions and the way delay is incorporated. To this end, we generalize the dynamical model to allow more general functions and an alternative way of incorporating time delay. Our findings show that in theory, such models can possess unstable positive steady states and produce oscillatory solutions. However, for all the clinic data reported in [4] , such unstable steady states do not exist. Hence, our work indicates that the dynamic model does provide qualitatively robust dynamics for the purpose of clinic application. We also perform simulations based on data from a clinic study reported in [4] and point out some plausible but important implications.
We would like to point out that oscillation in human insulin secretion have been observed in two distinct period ranges, 10-15 min (i.e., rapid) and 80-150 min (i.e., ultradian) ( [16] , [15] ). Often, the rapid oscillation is superimposed on the slow (ultradian) oscillaton. To determine whether the ultradian oscillations could result from the interaction between insulin and glucose, a parsimonious nonlinear mathematical model consisting six ordinary differential equations including the major mechanisms involved in glucose regulation was developed by Sturis et al. [17] and recently simplified by Tolic et al. [20] (which also contains more sophisticated receptor down-regulation model and receptor-modification model). More recently, this model was modified by incorporating delayed hepatic glucose production explicitly and systematically studied by Engelborghs et al. [7] via numerical bifurcation analysis. This model comprises two major negative feedback loops describing the effects of insulin on glucose utilization and glucose production, respectively, and both loops include the stimulatory effect of glucose on insulin secretion. The occurrence of sustained insulin and glucose oscillations was found numerically to be dependent on two essential features: 1) a time delay of 30-45 min for the effect of insulin on glucose production and 2) a sluggish effect of insulin on glucose utilization. Clearly, both "minimal model" and "dynamical model" do not account for the delayed (by about 30-45 minutes) influence of insulin on the hepatic glucose production ( [17] ) and are not constructed for the understanding of insulin oscillation. Their main purpose is to model the intra venous glucose tolerance test conducted for the study of metabolism of glucose.
The paper is organized as follows. We present our general model and two other less general ones(still more general than the dynamic model), and their basic properties in the next section. Section 3 contains some general global stability results. Section 4 present a formal derivation of linearization and characteristic equations. Section 5 provides some delay independent local stability results and section 6 gives delay dependent stability conditions. Guided by the results of section 6, we performed extensive computer simulation(using clinic data) and succeeded in finding periodic solutions in our discrete delay model. Some of these simulation findings are reported in the last section, which also contains a brief discussion on the implications of our results.
Model and Preliminaries.
We propose the following general and more realistic model for the interaction of glucose and insulin. This model includes the "dynamic model" (1.2) as a special case:
The initial condition is 5 and b 7 are the same as in model (1.2). Functions f , g, p, q satisfy the following general conditions.
( 
with the same initial conditions of (2.1). The parameters have the same meaning as those in "dynamic model" (1.2).
Comparing with the "dynamic model" (1.2), model (2.2) has two notable and important differences: First, no mass action law is assumed for glucose concentration change due to the insulin-dependent net glucose tissue uptake. We assume instead that insulin-dependent net glucose tissue uptake takes the more general and realistic Michaelis-Menten form G(t)/(αG(t) + 1) which has a maximum capacity b 4 /α. The parameter α in the response function G(t)/(αG(t) + 1) is non-negative. 1/α is the half-saturation constant. The reason for this is simply due to the limit of time and the capacity of insulin's ability of digesting glucose. Second, we assume that the effective pancreatic secretion (after the liver first-pass effect) at time t is affected by the value of glucose concentration in the b 5 minutes preceding time t instead of the average amount in that period.
When
and the Michaelis-Menten kinetics is assumed, the model (2.1) becomes
Clearly, both models (2.2) and (2.3) have a unique equilibrium point (G
x(s)ds and α = 0, model (2.1) reduces to the dynamic model (1.2). For convenience, we define two new parameters a 1 , γ for models (2.2) and (2.3):
The following basic proposition is important for our study. Its proof is straightforward. Proof Let (G(t), I(t)) be a solution of (2.1). If G(t 0 ) = 0 for some t 0 > 0, then G (t 0 ) ≤ 0. However, at t 0 , due to the assumptions that
and thus I(t) > 0 for all t in the interval of existence.
As for the boundedness of G(t), by the first equation of (2.1),
The boundedness statement implies that solutions exist for all t > 0. This completes the proof.
Let (G(t), I(t)
) be a solution of (2.1). Throughout this paper, we define
I(t).
Due to the Proposition 2.1, we see that these limits are finite.
The following fluctuation lemma is elementary. We state it below without proof.
The following lemma is useful for establishing the fact that model (2.1) is always uniformly persistent, which implies that both components of solutions of the model are eventually bounded by positive constants from both above and below. Such bounds are independent of initial data.
Lemma 2.1. Consider model (2.1). If I < I, then
) is a solution of (2.1). Hence, we have
For any ε > 0, there exists k 0 > 0, such that
By letting k→∞ and ε→0, we have
Similarly, we have Therefore
(2.5) and (2.6) lead to
and then
Since f, g are continuous and g 2 (x, y) > 0 for all x > 0, without loss of generality, assuming lim k→∞ I(t k ) and lim k→∞ I(s k ) exist, we have
This completes the proof.
Proposition 2.2. The model (2.1) is uniformly persistent. That is, solutions are eventually uniformly bounded by positive constants from both above and below.
Proof For a solution (G(t), I(t)) of (2.1), by Proposition 2.1,
Using Lemma A, we can obtain that
which shows that G > 0. This together with Lemma (2.1) shows that the model (2.1) is uniformly persistent. 
for all x ≥ y > 0, then the unique equilibrium point (G * , I * ) of (2.1) is globally asymptotically stable.
Proof If I < I, then from Lemma 2.1,
Thus G < G and
Due to (3.1), we have
Hence
which indicates G = G and thus I = I. Since (G * , I * ) is the only equilibrium point of (2.1), we have
The proof is completed.
Theorem 3.2. For model (2.1), if
for all x, y > 0, then the unique equilibrium point (G * , I * ) of (2.1) is globally asymptotically stable.
we see that G < G, and
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Then (3.3) is equivalent to
By the mean value theorem, there exists a θ ∈ (0, 1) such that
where ξ
and
.
On the other hand, (3.4) and (3.5) lead to
Clearly, (3.6) leads to G − G ≤ 0 and thus G = G and I = I. Since (G * , I * ) is the only equilibrium point of (2.1), we have
In model (2.1), if g(x, y) takes the special form
Proof We shall show that G = G and I = I. By Lemma 2.1, if I < I, then G < G and
Hence, (3.7) and (3.8) imply
This together with the assumptions (a) and (b), we obtain
This implies that G = G, and therefore I = I. This completes the proof.
Proof We shall show that (b) in Theorem 3.3 is true when (b ) holds. Let
By the mean value theorem, for x ≥ y > 0, there exists θ ∈ (0, 1) such that
. This completes the proof.
The following are direct results of the applications of the above theorems to the specific models (2.2) and (2.3). 
For (b) to hold, we need only to observe that
Combining the above two corollaries, we immediately arrive at the following conclusion Corollary 3.4. For model (2.2) ((2.3)), if a 1 ≥ γ, i. e., We would like to know if and how this may change for more realistic models. To this end, we need to obtain the characteristic equations associated to our models. Consider first model (2.1). Let
then model (2.1) is translated to
and has a unique equilibrium point at (0, 0). Thus the linearized system of (4.2) is given by
For convenience, we still use G(t) and I(t) to represent G 1 (t) and I 1 (t), respectively, and define
Then A, B, C and D are positive. The linearized system of (4.2) can be rewritten as
G (t) = −AG(t) − BI(t) I (t) = −DI(t) + CL(G t ). (4.3)
It's easy to see that
G (t) = −(A + D)G (t) − ADG(t) − BCL(G t ). (4.4)
Denote that
Then (4.4) can be rewritten as
If L(G t ) takes the discrete delay form, i.e., L(G t ) = G(t − τ ), t > 0, then the characteristic equation of (4.5) is given by Theorem B In the following second order real scalar linear neutral delay equation (II) If there are any imaginary roots with positive imaginary part, an unstable zero solution never becomes stable for any τ ≥ 0. If the zero solution is asymptotically stable for τ = 0, then it is uniformly asymptotically stable for τ < τ 0 , and it becomes unstable for τ > τ 0 where τ 0 > 0 is a constant. It undergoes a supercritical Hopf bifurcation at τ = τ 0 .
(III) If there are two imaginary roots with positive imaginary part, iω + and iω − , such that ω + > ω − > 0, then the stability of the zero solution can change (when changes from stable to unstable, the zero solution undergoes a supercritical Hopf bifurcation) a finite number of times at most as τ is increased, and eventually it becomes unstable.
The number of such roots are determined by the following conditions. 
Otherwise, there is no such solution.
Lemma 5.1. In (4.6), the stability of (0, 0) is determined as follows. Case (1) . If AD > BC, then the stability of (0, 0) does not change as τ ≥ 0 is increasing;
Case (2) . If AD ≤ BC, then the stability of (0, 0) can at most change once from stable to unstable, i. Proof Compare (4.6) with (5.1). We have
Thus,
Hence, (A) is violated, and hence the case (III) in (Theorem B). That is, (0, 0) cannot have multiple stability switches. For (2.1) , we have the following results on the local stability of (0, 0).
* ) has at most one stability switch as τ ≥ 0 increases.
then stability of (G * , I * ) does not change for any τ ≥ 0.
Proof Notice that (4.3) is the linearized system of (2.1) at (G * , I * ), and Proof By Theorem 5.1, we need only to check the sign of
Notice that
Then (5.3) becomes
Then sign (5.3) = sign w 1 (α). We have
Let µ = √ α and
Notice that Assume now that ∆ J > 0, i.e., γ − 3a 1 > 0. We shall find the minimum value of J(µ), µ ≥ 0. Solving J (µ) = 0, we obtain
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Clearly
6. Delay Dependent Stability Conditions. The stability results in the previous section do not depend on the values of the delay(b 5 ). However, they do suggest that for some parameter values(delay is included), the positive steady state may become unstable. It is thus interesting to locate such parameter values. Such task turns out to be very complex. Instead, we shall single out parameter region where no stability switch can take place. Specifically, we would like to obtain some upper bound on the delay length(while holding other parameters steady) for the positive steady state to remain stable. Specifically, we shall seek the relationship of such upper bound with the value of α. We shall consider both model (2.2) and (2.3).
Recall that the following notations in Section 4,
6.1. The case of discrete delay. We shall consider here the characteristic equation (4.6) below. Recall that
If there exists a τ 0 > 0 such that the trivial solution of (4. Applying theorem 6.1 to model (2.2), we have 
If the trivial solution of (4.5) is unstable for some τ > 0, then there exist u ≥ 0 and v > 0 such that λ = u + iv is a solution of (6.2), i.e.,
Thus Since v > 0, we see that (6.4) implies
Hence we have u ≤ 
In this case, we have Table 1 . Parameter values for subjects 6 and 7, from De Gaetano and Arino [4] . P stands for parameters, U stands for units and 6, 7 stand for subject 6, 7, respectively.
4). Let S(α)
7. Simulation and discussion. In a clinic study reported in [4] , ten healthy volunteers participated(5 males and 5 females). All of them had negative family and personal histories for diabetes mellitus and other endocrine diseases, were on no medications and had maintained a constant weight for the six months preceding that study. For detailed experiment description, see [4] . They were able to show that the dynamic model does produce solutions that fit well with the data collected from that experiment. The parameter values for these individuals are listed in their Table 1 . Using these parameters and Corollary 3.4, we found that for all these persons except the sixth person(female) and the seventh person(male), and all values of α and delay lengths, solutions always tend to the positive steady state for both models (2.2) and (2.3). Since one of our main objectives is to see if unstable positive steady state is possible for our models and some of these ten persons, and our theoretical results failed to exclude such possibility, we thus focused our simulations on the subjects 6 and 7(sixth and seventh persons). The relevant parameter values(obtained through the above mentioned clinic study) for these two persons are summarized in table 1. Even for subjects 6 and 7, according to our extensive computer simulation work by XPP for window 98/NT ( [8] ), the steady state is globally asymptotically stable in all practically meaningful values of time delay τ = b 5 and α. Nevertheless, we did find that the positive steady state can be unstable(if a 1 < γ and α ∈ (a 1 , γ) provided the delay is large enough). Figures 1-2 illustrate such instability with nontrivial periodic solutions for the discrete delay model (2.2), using the data (except b 5 and α) given in the table 1 for subjects 6 and 7. For discrete delay model (2.2), we need the time delay to be as long as close to 550 minutes in order to observe sustainable oscillatory solutions for both subjects 6(550) and 7(600). The values of α are 0.01 and 0.05 for subject 6 and subject 7, respectively. Since for both subjects, the actual delay length is only 23 minutes , we believe that it is very unlikely to observe any sustainable oscillatory solutions in real life experiments for these subjects. In other word, the global asymptotical results reported in [4] is confirmed at least practically by the more general model (2.1). From purely theoretical point of view, we can still make a few insightful statements. For both very large or small values of α, the positive steady stable is believed to be globally asymptotically stable for any conceivable persons. For relatively small α and large delay, oscillatory solutions become possible. This indicates that it is important to have α in the model, since the value of α is most likely small, but not too small. Indeed, from the simulation results( figures 1-2 
In view of the fact that the values of b 1 (from 0.0001 to 0.0565) and b 4 (from 3.51E-08 to 3.73E-04) change significantly from one person to another, we see that the likely candidates for having sustainable oscillatory glucose and insulin levels are subjects that have high values of b 4 (insulin-dependent glucose disappearance rate) and low values of b 1 (the spontaneous or insulin-independent glucose first order disappearance rate). That is, those subjects who can not process their glucose quick enough when insulin level is low but respond very well with added insulin.
Roughly speaking, when the delay is short(less than 60 minutes), we probably will not see any sustainable oscillatory solutions. However, for large enough delays, this may be possible. In such cases, the larger the half-saturation constant (i.e., 1/α), the more likely that the steady state is to be unstable. Even when the delay is small and the steady state is stable, the solutions may converge to the steady state in an oscillatory way. This can give rise to subsequent peaks of glucose and insulin, as observed in the experiment of De Gaetano and Arino [4] . If α = 0, then we know the positive steady state is always locally stable. If α > 0, the positive steady state remains stable for small and medium delays. Only for large values of delay and appropriate values of α, the positive steady state may lose its stability. Therefore, delay or the saturating glucose uptake functional response(G/(αG + 1) alone will not destabilize the steady state. In other words, for model (2.1), oscillatory solutions resulted from delayed suitable nonlinear glucose uptake mechanism. More complex nonlinear glucose uptake mechanism can be found in [17] . This is in striking contrast to the well known predator-prey dynamics(see [11] ), where either alone will be enough to produce periodic solutions.
A potential application of our study here is to find better ways of delivering insulin and timing of the intake of glucose. Previous studies are largely done on linear compartment models ( [18] , [19] ) or on the minimal type models [9] . Our theoretical and simulation work shows that in clinic applications, we can safely assume that after about 40 minutes, solutions are close and stay close to steady state levels. Another possible usage of our work is to design effective ways to estimate the involved parameters for clinic applications. For minimal model, such effort is documented in [5] . The recent development of PET technology provides a possibility of effectively monitor subjects' glucose and insulin levels through noninvasive method [3] . This should be very helpful in estimating parameters for individuals in order to design proper controls for their glucose and insulin levels.
Model (2.1) is constructed for the study of IVGTT which focuses on the metabolism of glucose. More in-depth study of insulin-glucose interaction may need to take into account of the insulin influence on the hepatic glucose production. This may, however, increase the number of equations in a plausible mathematical model. Indeed, this is evidenced in the work of Sturis et al. [17] and Tolic et al. [20] . Their models consist of six nonlinear ordinary differential equations. Three of which tract the plasma insulin, intercellular insulin and glucose respectively. The other three are auxiliary linear chain equations used to mimic delay action between insulin in plasma and its effect on the hepatic glucose production. An alternative approach is to introduce such delay explicitly in the glucose equation which will reduce the number of equations from six to three. This is basically the approach of [7] , except that they made a further simplification assumption that plasma insulin concentration is the same as the intercellular insulin concentration. However, in [7] , they have also considered the possible continuous and theoretical external assistance to the patients (this artificial delivering of insulin results in the so-called technology delay). This yields a system of two nonlinear delay differential equations with two discrete delays, one in each equation. With or without such assistance, diabetic patients can exhibit intrinsic glucose oscillation. This reinforces the results reported in [17] . Our results show that in theory, even without hepatic glucose production, generalized dynamic model can produce oscillatory solutions.
